Below is a description of the Bridge HCV training offered in collaboration with Exchange CME

ADDICTION CENTERS

Credit: 1.0 hour inclusive of CME/CNE/CE credit provided by Purdue University.

Audience: 10-15 participants inclusive of clinical as well as non-clinical staffsocial workers, counselors, advisors, and advocates.

Agenda Topics: (Dr. Norton)
  • Understanding the need for referral and linkage to HCV care
  • The national and local epidemiologic imperative: HCV treatment as prevention within PWID populations
  • Barriers to treatment of HCV-positive PWID: addressing clinical assumptions regarding eligibility and prescribing limitations
  • Updates on clinical evidence for the feasibility and success of treating HCV-positive PWID
  • A holistic approach to harm reduction
  • Real-world integration: optimizing collaboration with HCV care specialists

HCV TREATMENT CENTERS

 Credit: This is a two-part education – each educational session is 1.0 hour (total of 2.0 hours of CME/CNE/CE credit) and scheduled about a week or two apart.

Audience:  10-15 participants inclusive of MDs, PhDs RNs, PAs, NPs, pharmacists, social workers, counselors as well as your non-clinical staff who support your patients.

 Agendas
Part 1: Keys to Successful Treatment of HCV in People Who Inject Drugs (Dr. Norton)
  • The national and local epidemiologic imperative: HCV treatment as prevention within PWID populations
  • Barriers to treatment of HCV-positive PWID: addressing clinical assumptions regarding eligibility and prescribing limitations
  • Updates on clinical evidence for the feasibility and success of treating HCV-positive PWID
  • Real-world integration: Optimizing sustained virologic response (SVR) and reinfection prevention in PWID
Part 2: Anatomy of Addiction (Includes a Harm Reduction Specialist with Dr. Norton)
  • The direct risks and clinical ramifications of injection practices
  • A holistic approach to harm reduction
  • The HCV treater’s role in overdose-death prevention
  • Educating the patient and the provider
  • Optimizing interdisciplinary collaboration in support of HCV-positive PWID

For more information, contact

Mara Simpson

Vice President, Account Services

Integritas Communications Group

Cell: 719-648-8204

msimpson@integritasgrp.com

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you. Thank you.

Sending

©2019 HepFree.NYC. All rights reserved. Site by Lookit Design QuikSite®

or

Log in with your credentials

Forgot your details?